Keywords
Immunocompromised
Panuveitis
Vaccination
How to Cite
Abstract
With the emergence of vaccines for the novel coronavirus, a new ray of hope came into human society. Yet the adverse effects of vaccination on some candidates without allergic tests might cause a detrimental change in the future. An interesting case of panuveitis in a 34-year-old male after the ChAdOx1 nCoV19 (covishield) vaccination is reported here. The respective management of the patient was done after comprehensive ocular and systemic evaluation. It is understood that vaccination is vital in controlling this pandemic, but the immunologic response due to this novel vaccine is also a concern.
References
Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American journal of ophthalmology. 2005 Sep 1;140(3):509-16.[FULLTEXT] [DOI]
Couture S, Agrawal R, Woods K, Lockwood D, Pavesio CE, Addison PK. A case of panuveitis with hypopyon due to presumed ocular leishmaniasis in a HIV patient. Journal of ophthalmic inflammation and infection. 2014 Dec;4(1):1-5. [FULLTEXT] [DOI]
Pinon-Mosquera R, Jimenez-Benito J, Olea-Cascon J. Syphilitic bilateral panuveitis: a case report. Archivos de la Sociedad Espanola de Oftalmologia. 2009 Feb 1;84(2):101-4. [FULLTEXT] [DOI]
Tien PT, Lin CJ, Tsai YY, Chen HS, Hwang DK, Muo CH, Lin JM, Chen WL. Relationship between uveitis, different types of viral hepatitis, and liver cirrhosis: a 12-year nationwide population-based cohort study. Retina (Philadelphia, Pa.). 2016 Dec;36(12):2391. [FULLTEXT] [DOI]
Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocular Immunology and Inflammation. 2021 May 19;29(4):741-2. [FULLTEXT] [DOI]
Reddy Y, Pandey A, Ojha A, Ramchandani S. Harada-like syndrome post-Covishield vaccination: A rare adverse effect. Indian journal of ophthalmology. 2022 Jan 1;70(1):321-3. [FULLTEXT] [DOI]
Chau CY, Chow LL, Sridhar S, Shih KC. Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders. Ophthalmology and Therapy. 2021 Jun;10(2):201-9. [FULLTEXT] [DOI]
Agarwal M, Majumder PD, Babu K, Konana VK, Goyal M, Touhami S, Stanescu-Segall D, Bodaghi B. Drug-induced uveitis: A review. Indian Journal of Ophthalmology. 2020 Sep;68(9):1799. [FULLTEXT] [DOI]
Vounotrypdis P. COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment. Mediterranean Journal of Rheumatology. 2020 Sep;31(Suppl 2):275. [FULLTEXT] [DOI]
Martins-Chaves RR, Gomes CC, Gomez RS. Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care. Brazilian oral research. 2020 May 15;34. [FULLTEXT] [DOI]
Ritchie AI, Singanayagam A. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?. The Lancet. 2020 Apr 4;395(10230):1111. [FULLTEXT] [DOI]